Quercetin alleviates high-fat diet-induced oxidized low-density lipoprotein accumulation in the liver: Implication for autophagy regulation

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Liu, Liang ^a   Gao, Chao ^b   Yao, Ping ^c   Gong, Zhiyong ^a  

^a WUHAN POLYTECHNIC UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; QUERCETIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MSR1 PROTEIN, MOUSE; SCAVENGER RECEPTOR A; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ARTICLE; AUTOPHAGY; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; LIPID DEGRADATION; LIPID DIET; LIVER INJURY; MALE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; HUMAN; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

ANIMALS; ANTIGENS, CD36; AUTOPHAGY; CHOLESTEROL; DIET, HIGH-FAT; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS, LDL; LIVER; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NON-ALCOHOLIC FATTY LIVER DISEASE; QUERCETIN; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS A; TOR SERINE-THREONINE KINASES;

EID: 84949963411     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/607531     Document Type: Article

References (51)

1. N. N. Than and P. N. Newsome, "A concise review of nonalcoholic fatty liver disease," Atherosclerosis, vol. 239, no. 1, pp. 192-202, 2015.
2. J. B. Moore, "Non-alcoholic fatty liver disease: The hepatic consequence of obesity and the metabolic syndrome," Proceedings of the Nutrition Society, vol. 69, pp. 211-220, 2010.
3. V. Bieghs, P. J. van Gorp, S. M. A. Walenbergh et al., "Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice," Hepatology, vol. 56, no. 3, pp. 894-903, 2012.
4. G. K. Hansson, "Inflammation, atherosclerosis, and coronary artery disease," The New England Journal of Medicine, vol. 352, no. 16, pp. 1685-1695, 2005.
5. S. M. A. Walenbergh, G. H. Koek, V. Bieghs, and R. Shiri-Sverdlov, "Non-alcoholic steatohepatitis: The role of oxidized low-density lipoproteins," Journal of Hepatology, vol. 58, no. 4, pp. 801-810, 2013.
6. V. Bieghs, F. Verheyen, P. J. van Gorp et al., "Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in kupffer cells," PLoS ONE, vol. 7, no. 3,Article ID e34378, 2012.
7. V. Bieghs, K. Wouters, P. J. van Gorp et al., "Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice," Gastroenterology, vol. 138, no. 7, pp. 2477-2486, 2010.
8. V. Bieghs, S. M. A. Walenbergh, T. Hendrikx et al., "Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation," Liver International, vol. 33, no. 7, pp. 1056-1061, 2013.
9. M. Lougheed,H. F. Zhang, andU. P. Steinbrecher, "Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages,"The Journal of Biological Chemistry, vol. 266, no. 22, pp. 14519-14525, 1991.
10. J. Herrmann, S. M. Soares, L. O. Lerman, and A. Lerman, "Potential role of the ubiquitin-proteasome system in atherosclerosis: Aspects of a protein quality disease," Journal of the American College of Cardiology, vol. 51, no. 21, pp. 2003-2010, 2008.
11. Y.-L. Zhang,Y.-J.Cao, X. Zhang et al., "Theautophagy-lysosome pathway: A novel mechanism involved in the processing of oxidized LDL in human vascular endothelial cells," Biochemical and Biophysical Research Communications, vol. 394, no. 2, pp. 377-382, 2010.
12. M.G.L.Hertog, E. J.M. Feskens, P. C. H. Hollman,M. B. Katan, and D. Kromhout, "Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study," The Lancet, vol. 342, no. 8878, pp. 1007-1011, 1993.
13. J. Kühnau, "The flavonoids. A class of semi-essential food components: Their role in human nutrition," World Review of Nutrition and Dietetics, vol. 24, pp. 117-191, 1976.
14. J. Lin, K. M. Rexrode, F. Hu et al., "Dietary intakes of flavonols and flavones and coronary heart disease in US women," American Journal of Epidemiology, vol. 165, no. 11, pp. 1305-1313, 2007.
15. L. Sampson, E. Rimm, P. C. H. Hollman, J. H. M. De Vries, and M. B. Katan, "Flavonol and flavone intakes in US health professionals," Journal of the American Dietetic Association, vol. 102, no. 10, pp. 1414-1420, 2002.
16. H.-Z. Ying, Y.-H. Liu, B. Yu, Z.-Y.Wang, J.-N. Zang, and C.-H. Yu, "Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils," Food and Chemical Toxicology, vol. 52, pp. 53-60, 2013.
17. K. M. Surapaneni, V. V. Priya, and J. Mallika, "Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH)," European Review forMedical and Pharmacological Sciences, vol. 18, no. 18, pp. 2736-2741, 2014.
18. K. M. Surapaneni and M. Jainu, "Comparative effect of pioglitazone, quercetin and hydroxy citric acid on the status of lipid peroxidation and antioxidants in experimental non-alcoholic steatohepatitis," Journal of Physiology and Pharmacology, vol. 65, no. 1, pp. 67-74, 2014.
19. S. Vidyashankar, V. R. Sandeep, and P. S. Patki, "Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells," Toxicology in Vitro, vol. 27, no. 2, pp. 945-953, 2013.
20. E. Marcolin, B. San-Miguel, D. Vallejo et al., "Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis," Journal of Nutrition, vol. 142, no. 10, pp. 1821-1828, 2012.
21. S. Pisonero-Vaquero, A. Mart?nez-Ferreras, M. V. Garć?a-Mediavilla et al., "Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of non-alcoholic fatty liver disease," Molecular Nutrition & Food Research, vol. 59, no. 5, pp. 879-893, 2015.
22. C. H. Jung, I. Cho, J. Ahn, T.-I. Jeon, and T.-Y. Ha, "Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes," Phytotherapy Research, vol. 27, no. 1, pp. 139-143, 2013.
23. E. Marcolin, L. F. Forgiarini, G. Rodrigues et al., "Quercetin decreases liver damage in mice with non-alcoholic steatohepatitis," Basic and Clinical Pharmacology and Toxicology, vol. 112, no. 6, pp. 385-391, 2013.
24. A. K. Klappan, S. Hones, I. Mylonas, and A. Brüning, "Proteasome inhibition by quercetin triggers macroautophagy and blocksmTOR activity," Histochemistry and Cell Biology, vol. 137, no. 1, pp. 25-36, 2012.
25. X. Zhang, L.-X. Chen, L. Ouyang, Y. Cheng, and B. Liu, "Plant natural compounds: Targeting pathways of autophagy as anticancer therapeutic agents," Cell Proliferation, vol. 45, no. 5, pp. 466-476, 2012.
26. K. Wang, R. Liu, J. Li et al., "Quercetin induces protective autophagy in gastric cancer cells: Involvement of Akt-mTORand hypoxia-induced factor 1α-mediated signaling," Autophagy, vol. 7, no. 9, pp. 966-978, 2011.
27. O. Saeed, F. Otsuka, R. Polavarapu et al., "Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 2, pp. 299-307, 2012.
28. Y. Tang, Y. Li, H. Yu et al., "Quercetin prevents ethanolinduced iron overload by regulating hepcidin through the BMP6/SMAD4 signaling pathway," Journal of Nutritional Biochemistry, vol. 25, no. 6, pp. 675-682, 2014.
29. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, "Protein measurement with the Folin phenol reagent," The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265-275, 1951.
30. N. Grewal, G. M.Thornton, H. Behzad et al., "Accumulation of oxidized LDL in the tendon tissues of C57BL/6 or apolipoprotein E knock-out mice that consume a high fat diet: Potential impact on tendon health," PLoS ONE, vol. 9, no. 12, Article ID e114214, 2014.
31. J. K. Dyson, Q. M. Anstee, and S. McPherson, "Non-alcoholic fatty liver disease: A practical approach to treatment," Frontline Gastroenterol, vol. 5, pp. 277-286, 2014.
32. G. Kanuri and I. Bergheim, "In vitro and in vivomodels ofNon-Alcoholic Fatty Liver Disease (NAFLD)," International Journal of Molecular Sciences, vol. 14, no. 6, pp. 11963-11980, 2013.
33. B. W. Smith and L. A. Adams, "Nonalcoholic fatty liver disease and diabetes mellitus: Pathogenesis and treatment," Nature Reviews Endocrinology, vol. 7, no. 8, pp. 456-465, 2011.
34. S. Sookoian and C. J. Pirola, "Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review," Journal of Hepatology, vol. 49, no. 4, pp. 600-607, 2008.
35. G. Targher, L. Bertolini, R. Padovani, S. Rodella, G. Arcaro, and C.Day, "Differences and similarities in early atherosclerosis between patientswith non-alcoholic steatohepatitis and chronic hepatitis B and C," Journal of Hepatology, vol. 46,no. 6, pp. 1126-1132, 2007.
36. A. Brea, D. Mosquera, E. Mart?n, A. Arizti, J. L. Cordero, and E. Ros, "Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: A case-control study," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 5, pp. 1045-1050, 2005.
37. Y. Luo, X. Dong, Y. Yu, G. Sun, and X. Sun, "Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis bymodulating IRE1α-mediated JNK and NF-κB pathways inApoE?/? mice," Journal of Ethnopharmacology, vol. 163, pp. 241-250, 2015.
38. M. Kampschulte, C. Stöckl, A. C. Langheinrich et al., "Western diet in ApoE-LDLR double-deficient mouse model of atherosclerosis leads to hepatic steatosis, fibrosis, and tumorigenesis," Laboratory Investigation, vol. 94, no. 11, pp. 1273-1282, 2014.
39. M. C. Morrison, W. Liang, P. Mulder et al., "Mirtoselect, an anthocyanin-rich bilberry extract, attenuates non-alcoholic steatohepatitis and associated fibrosis in ApoE?3Leiden mice," Journal of Hepatology, vol. 62, no. 5, pp. 1180-1186, 2015.
40. A. Stachowicz, R. Olszanecki, M. Suski et al., "Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice," Journal of the American Heart Association, vol. 3, no. 6,Article ID e001329, 2014.
41. K.Wouters, P. J. van Gorp, V. Bieghs et al., "Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis," Hepatology, vol. 48, no. 2, pp. 474-486, 2008.
42. V. V. Kunjathoor, M. Febbraio, E. A. Podrez et al., "Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages," The Journal of Biological Chemistry, vol. 277, no. 51, pp. 49982-49988, 2002.
43. S. Yao, H. Sang, G. Song et al., "Quercetin protects macrophages from oxidized low-density lipoprotein-induced apoptosis by inhibiting the endoplasmic reticulum stress-C/EBP homologous protein pathway," Experimental Biology and Medicine, vol. 237, no. 7, pp. 822-831, 2012.
44. H. J. Choi, J. H. Song, and D. H. Kwon, "Quercetin 3-rhamnoside exerts antiinfluenza A virus activity in mice," Phytotherapy Research, vol. 26, no. 3, pp. 462-464, 2012.
45. O. J. Lara-Guzman, J. H. Tabares-Guevara, Y. M. Leon-Varela et al., "Proatherogenic macrophage activities are targeted by the flavonoid quercetin," Journal of Pharmacology and Experimental Therapeutics, vol. 343, no. 2, pp. 296-306, 2012.
46. V. J. Lavallard and P. Gual, "Autophagy and non-alcoholic fatty liver disease," BioMed Research International, vol. 2014, Article ID120179, 13 pages, 2014.
47. W. J.Kwanten,W.Martinet, P. P.Michielsen, and S. M. Francque, "Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: A controversial issue," World Journal of Gastroenterology, vol. 20, no. 23, pp. 7325-7338, 2014.
48. Yimin, H. Furumaki, S.Matsuoka et al., "A novelmurine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein," Laboratory Investigation, vol. 92, no. 2, pp. 265-281, 2012.
49. B.-L. Chen, L.-T. Wang, K.-H. Huang, C.-C. Wang, C.-K. Chiang, and S.-H. Liu, "Quercetin attenuates renal ischemia/reperfusion injury via an activation of AMP-activated protein kinase-regulated autophagy pathway," Journal of Nutritional Biochemistry, vol. 25, no. 11, pp. 1226-1234, 2014.
50. V. Maso, A. K. Calgarotto, G. C. Franchi et al., "Multitarget effects of quercetin in leukemia," Cancer Prevention Research, vol. 7, pp. 1240-1250, 2014.
51. N. Hasima and B. Ozpolat, "Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer," Cell Death and Disease, vol. 5, no. 11, article e1509, 2014.